{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:01:21Z","timestamp":1778122881575,"version":"3.51.4"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/ico.0b013e31823f766c","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T10:50:06Z","timestamp":1338979806000},"page":"1206-1209","source":"Crossref","is-referenced-by-count":15,"title":["Fungal Keratitis Responsive to Moxifloxacin Monotherapy"],"prefix":"10.1097","volume":"31","author":[{"given":"Alice Y.","family":"Matoba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20210204","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/bjo.59.7.372","article-title":"Dematiaceous fungal keratitis. Clinical isolates and management.","volume":"59","author":"Forster","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"R2-21-20210204","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0008-4182(00)80107-6","article-title":". Tobramycin-responsive Fusarium oxysporum keratitis.","volume":"35","author":"Chodosh","year":"2000","journal-title":"Can J Ophthalmol"},{"key":"R3-21-20210204","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1001\/jama.295.24.2867","article-title":". An outbreak of Fusarium keratitis associated with contact lens wear in Singapore.","volume":"295","author":"Khor","year":"2006","journal-title":"JAMA"},{"key":"R4-21-20210204","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/ICO.0b013e318033e7e1","article-title":". Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.","volume":"26","author":"Munir","year":"2007","journal-title":"Cornea"},{"key":"R5-21-20210204","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/ICO.0b013e31813e32a6","article-title":". A case series of contact lens-associated Fusarium keratitis in Hong Kong.","volume":"26","author":"Rao","year":"2007","journal-title":"Cornea"},{"key":"R6-21-20210204","first-page":"513","article-title":". Quinolones in 2005: an update. Clin Microbiol Infect. 2005;11:256-280; Review.","volume":"11","author":"Van Bambeke","year":"2005","journal-title":"Erratum in: Clin Microbiol Infect"},{"key":"R7-21-20210204","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1128\/AAC.36.10.2131","article-title":"Characterization of DNA topoisomerase I from Candida albicans as a target for drug discovery.","volume":"36","author":"Fostel","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"R8-21-20210204","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1054-3589(08)61140-0","article-title":"DNA topoisomerase inhibitors as antifungal agents.","volume":"29B","author":"Shen","year":"1994","journal-title":"Adv Pharmacol"},{"key":"R9-21-20210204","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09273940600976953","article-title":". In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections.","volume":"14","author":"Ozdek","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"R10-21-20210204","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/bjo.2008.142364","article-title":". Activity of antibiotics against Fusarium and Aspergillus.","volume":"93","author":"Day","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R11-21-20210204","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1128\/AAC.00735-07","article-title":". Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus.","volume":"52","author":"Stergiopoulou","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-21-20210204","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/AAC.39.7.1517","article-title":". In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi.","volume":"39","author":"Nakajima","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-21-20210204","first-page":"9","article-title":"In-vitro activity of antifungal agents in combination with four quinolones.","volume":"14","author":"Petrou","year":"1988","journal-title":"Drugs Exp Clin Res"},{"key":"R14-21-20210204","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.41.11.2518","article-title":"Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs.","volume":"41","author":"Sugar","year":"1997","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e31823f766c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:33:36Z","timestamp":1621884816000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201210000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31823f766c","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}